Wilson Wu
Impact in
- Oncology top 10%
- Pancreatic and Hepatic Oncology Research
- Cancer Cells and Metastasis
- Cancer Immunotherapy and Biomarkers
-
- Cancer Genomics and Diagnostics
Papers in
-
- Angiogenesis and VEGF in Cancer 3
- Oncology 7
- Pancreatic and Hepatic Oncology Research 4
- Co-authors
- Andrea J. Bullock (6 shared papers)Sunil R. Hingorani (7 shared papers)Tara Elisabeth Seery (6 shared papers)Sihem Khelifa (4 shared papers)Carrie Aldrich (4 shared papers)Ping Jiang (4 shared papers)Andrew Hendifar (7 shared papers)Nathan Bahary (6 shared papers)
- Journals
- Annals of Oncology (7 papers)Journal of Clinical Oncology (2 papers)Optics Express (2 papers)Journal of Chemical Information and Modeling (1 paper)Molecules (1 paper)
- Partner nations
- United StatesUnited KingdomChina
In The Last Decade
Wilson Wu
15 papers receiving 461 citations
Wilson Wu's Hit Papers
Peers
Comparison fields: 5 of 56
- Oncology 296
- Cancer Research 106
- Immunology 96
- Cell Biology 51
- Biotechnology 25
Countries citing papers authored by Wilson Wu
This map shows the geographic impact of Wilson Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wilson Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wilson Wu more than expected).
Fields of papers citing papers by Wilson Wu
This network shows the impact of papers produced by Wilson Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wilson Wu. The network helps show where Wilson Wu may publish in the future.
Co-authors
The 25 scholars most cited alongside Wilson Wu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | HALO 202: Randomized Phase II Study of PEGPH20 Plus Nab-Paclitaxel/Gemcitabine Versus Nab-Paclitaxel/Gemcitabine in Patients With Untreated, Metastatic Pancreatic Ductal Adenocarcinoma Hit paper breakdown → | 2017 | 378 |
| 2 | 2020 | 40 | |
| 3 | 2014 | 17 | |
| 4 | 2017 | 5 | |
| 5 | 2025 | 5 | |
| 6 | 2024 | 4 | |
| 7 | 2021 | 4 | |
| 8 | 2017 | 4 | |
| 9 | 2024 | 2 | |
| 10 | 2015 | 2 | |
| 11 | 2013 | 1 | |
| 12 | 2016 | 1 | |
| 13 | 2017 | 1 | |
| 14 | 2006 | 1 | |
| 15 | 2006 | 1 | |
| 16 | 2025 | 0 | |
| 17 | 2025 | 0 | |
| 18 | 2018 | 0 | |
| 19 | 2017 | 0 | |
| 20 | 2006 | 0 |
About Wilson Wu
Wilson Wu is a scholar working on Molecular Biology, Oncology, Electrical and Electronic Engineering, Hepatology and Artificial Intelligence, having authored 20 papers that have together received 466 indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (5 papers), Pancreatic and Hepatic Oncology Research (4 papers), Angiogenesis and VEGF in Cancer (3 papers), Electromagnetic Compatibility and Noise Suppression (3 papers), Magnetic Field Sensors Techniques (2 papers), Computational Drug Discovery Methods (2 papers), Electrical Contact Performance and Analysis (2 papers) and Quantum Information and Cryptography (2 papers). The work is most often cited by research in Oncology (296 citations), Cancer Research (106 citations), Immunology (96 citations), Cell Biology (51 citations) and Biotechnology (25 citations). Wilson Wu has collaborated with scholars based in United States, United Kingdom and China. Frequent co-authors include Andrea J. Bullock, Sunil R. Hingorani, Tara Elisabeth Seery, Sihem Khelifa, Carrie Aldrich, Ping Jiang, Andrew Hendifar, Nathan Bahary, William Proctor Harris and Darren Sigal. Their work appears in journals such as Annals of Oncology, Journal of Clinical Oncology, Optics Express, Journal of Chemical Information and Modeling and Molecules.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.